Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Role of Inhaled Nitric Oxide (iNO) on Pulmonary Hemodynamics in Patients With Intermediate/Submassive and Massive Pulmonary Embolism (PE)

NCT04996667 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04996667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04996667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Role of Inhaled Nitric Oxide (iNO) on Pulmonary Hemodynamics in Patients With Intermediate/Submassive and Massive Pulmonary Embolism (PE)
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Withdrawn
Start date
June 1, 2026
Completion date
June 30, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism, pulmonary embolism subacute massive